. Chronic rejection and long-term graft loss are significant problems in human organ transplantation. The applicants have shown, in preliminary experiments with rats, that allograft survival can be improved by the administration of donor bone marrow cells that have been co-cultured with splenocytes. The cultured cells can be fractionated, with some fractions having more activity than others, thereby allowing better phenotype definition of the active cell type(s). The applicants propose to culture human bone marrow, examining different culture conditions in order to obtain an analogous cell population with human cells. The cells will be characterized and compared to the rat culture results, with the ultimate goal being the use of cultured, and perhaps fractionated, human bone marrow cells in human organ transplantation to induce tolerance.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI043148-01
Application #
2647345
Study Section
Special Emphasis Panel (ZRG2-SSS-3 (51))
Project Start
1998-06-01
Project End
1999-02-28
Budget Start
1998-06-01
Budget End
1999-02-28
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Nova Cell Biotechnologies
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45219